Clinical Trial Update: Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a new agent for advanced breast cancer has been completed, sponsored by Bayer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Bayer | Conditions: Breast Neoplasm | Phase 2 | Status: COMPLETED